Patent · US Active

In vitro method of predictive assessment of the prospects of success of an implant and/or transplant

US9828636B2 · kind B2 · utility

0Cited by

1References

7Claims

0Family size

Assignee

TETEC Tissue Engineering Technologies AG · DE

Inventors

Jürgen Mollenhauer · Reutlingen, DE
Christoph Gaissmaier · Tübingen, DE
Karin Benz · Eppingen, DE

Key dates

Filing date	Mar 20, 2014
Grant date	Nov 28, 2017
Priority date	—
Expiry date	Mar 20, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

An in vitro method of prognostically assessing tissue regeneration capacity and/or cellular potency and/or the prospects of success of an implantation and/or transplantation, wherein the transcriptome and/or the gene expression of cells, the gene expression originating from the transcriptome, are analyzed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.